Home Link
Join Pro
  • Sign up for free
  • Login to your account
  • Upload for free
  • Upload for free
  • Listen

    • Live now
    • Genres
    • Trending
    • Community
    • Premium for listeners
    • Unlimited replaysPlay shows as many times as you like
    • Offline listeningDownload shows and listen on the go
    • No adsEnjoy uninterrupted listening
    • Upfront tracklistsSee the full tracklist from the start
  • Creator tools

    • Pro for creators
    • Unlimited uploadsShare infinite shows and tracks
    • Live streamingBroadcast music without takedowns
    • HQ audioEnhance the quality of your uploads
    • MonetizationMake money with Tips & Subscriptions
    • StatsUse listener insights to up your game
    • Host taggingPublish one show to multiple profiles
    • CustomizationPersonalize your profile
    • PostsSend direct messages to your fans
    • Upgrade

    • Pro for CreatorsUpload unlimited shows and live stream without takedowns.
      when paid annually,
    • Premium for listenersListen to your favorite DJs and shows offline and without limits.
    • Blog
    • Terms of use
    • Support
    • Privacy policy
    • About us
    • Jobs
    • Developers
  • HomeLive nowGenresTrendingLibraryPro for creatorsPremium for Listeners

    Ipilimumab

    Get the Mixcloud app

    App StoreGoogle Play Store
    • Blog
    • Terms of use
    • Support
    • Privacy policy
    • About us
    • Jobs
    • Developers

    Partners

    • TrackdropMusic promotion
    • EncoreGig bookings
    Popular Latest
    FirstWord Pharmaceutical News for Monday, June 7, 2010
    Track
    FirstWord Pharmaceutical News
    16 years ago
    FirstWord Pharmaceutical News for Monday, June 7, 2010

    avastin

    crizotinib

    ipilimumab

    eribulin

    prolia

    avastin

    crizotinib

    ipilimumab

    eribulin

    prolia

    Advances in Metastatic Melanoma Care
    Cancer Network Podcasts
    13 years ago
    Advances in Metastatic Melanoma Care

    melanoma

    braf

    inhibitor

    vemurafenib

    ipilimumab

    melanoma

    braf

    inhibitor

    vemurafenib

    ipilimumab

    Nivolumab: Promising Survival Signal Coupled with Limited Toxicity Raises Expectations
    Journal of Clinical Oncology P
    12 years ago
    Nivolumab: Promising Survival Signal Coupled with Limited Toxicity Raises Expectations

    immunotherapy

    ipilimumab

    nivolumab

    immunogenicintensification

    immunotherapy

    ipilimumab

    nivolumab

    immunogenicintensification

    FirstWord Pharmaceutical News for Wednesday, November 3, 2010
    Track
    FirstWord Pharmaceutical News
    15 years ago
    FirstWord Pharmaceutical News for Wednesday, November 3, 2010

    pfizer

    ipilimumab

    concerta

    pulmicort respules

    gemzar

    pfizer

    ipilimumab

    concerta

    pulmicort respules

    gemzar

    FirstWord Pharmaceutical News for Thursday, August 19, 2010
    Track
    FirstWord Pharmaceutical News
    15 years ago
    FirstWord Pharmaceutical News for Thursday, August 19, 2010

    johnson & johnson

    ipilimumab

    novartis

    jzp-6

    biogen idec

    johnson & johnson

    ipilimumab

    novartis

    jzp-6

    biogen idec

    FirstWord Pharmaceutical News for Wednesday, March 23, 2011
    Track
    FirstWord Pharmaceutical News
    15 years ago
    FirstWord Pharmaceutical News for Wednesday, March 23, 2011

    ipilimumab

    xoma

    sanofi-aventis

    xiaflex

    abbott

    ipilimumab

    xoma

    sanofi-aventis

    xiaflex

    abbott

    There is no more content to load